EPC1/2通过调节H3乙化和DLST来调节造血干细胞和祖细胞的增殖
WenYe Liu1, Xi Liu1, LingYa Li1
1College of Fisheries, Key Laboratory of Freshwater Animal Breeding, Ministry of Agriculture, Huazhong Agricultural University, Wuhan 430070, China.
iScience
|March 5, 2024
概括
聚1和2增强剂 (EPC1/2) 对于造血干细胞和原生细胞 (HSPC) 发育至关重要. 它们的枯竭会通过调节素乙化和DLST表达来损害HSPC的扩散和出现.
科学领域:
- 发展生物学 发展生物学
- 血液形成 血液形成 血液形成
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 聚基1 (EPC1) 和2 (EPC2) 的增强剂是转录辅因子,参与了基因素乙化.
- EPC1/2的功能障碍与发育缺陷和疾病有关,但它们在造血干细胞和原生细胞 (HSPC) 缺陷中的作用尚不清楚.
研究的目的:
- 调查EPC1和EPC2在HSPCs的发展和扩散中的作用.
- 阐明EPC1/2功能障碍影响HSPC出现的分子机制.
主要方法:
- 在相关的细胞模型中,EPC1/2的耗尽.
- 在特定的胚胎区域 (大动脉 - 淋巴体中和尾部造血组织) 分析HSPC数量.
- 对HSPC相关基因和DLST的基因表达分析.
- 评估基因素H3乙化水平.
主要成果:
- 通过削弱扩散,EPC1/2的消耗显著减少了HSPC的数量.
- 在EPC1/2-贫乏的K562细胞中观察到HSPC基因和DLST表达的下调.
- EPC1/2调节素H3的乙化,影响DLST表达,并与转录因子SRF和FOXR2合作.
结论:
- EPC1/2对于HSPC的出现和扩散至关重要.
- EPC1/2调节H3乙化,影响DLST表达,并将表观遗传调节与HSPCs中的线粒体代谢联系起来.
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
01:14Maintenance of the ES Cell State
2.2K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K
01:28Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K